Health
  • FaceBook
  • Twitter
  • Pin It
  • Linkedin
  • Buffer
  • WhatsApp

CACOVID Frowns At BUA's Claim Of Purchasing Covid Vaccines

The coalition against covid-19 (CACOVID) yesterday, expressed dismay over insinuations on social media alleging that BUA is singlehandedly bankrolling the purchase of one million covid-19 vaccine doses for Nigeria.

In a statement linked to the CACOVID operations committee and made available to IgbereTv, “Alhaji Rabiu Abdulsamad must have been misquoted because these claims are not factual as CACOVID operates on a collegiate fund contribution model. There is no agreement between BUA, CACOVID and Afreximbank.”

Continuing, he explained thus, “during the CACOVID weekly call of February 8th, Governor Emefiele of the CBN relayed to the larger group a call that he held with Alhaji Aliko Dangote and Herbert Wigwe with Afreximbank president Oramah on Sunday, February 7th. President Oramah briefed the three CACOVID leaders on the $ 2billion facility the bank has set up with the African Union vaccine taskforce to purchase vaccines for the African continent. The allocation for Nigeria has been capped at 42 million doses. President Oramah further explained that one million doses we’re ready for shipment to Nigeria in the next two weeks if down payment was made by yesterday, February 8th.

“At today’s meeting, CACOVID leadership agreed to contribute $100 million to procure vaccines for Nigeria. Thses include doses from Afreximbank worth $ 3.45 million, being the very first tranche. CACOVID will purchase vaccines through other credible and subsidized mechanism such as COVAX. The vaccines will be delivered to Nigeria and distributed through the Nigerian Primary Healthcare Development Agency (NPHCDA).

“CACOVID would like the Nigerian public to understand that vaccines purchase is only possible through the Federal Government of Nigeria and that no individual or company can purchase vaccines directly from any legitimate and recognized manufacturer.”

Gregory University Uturu, Abia State
  • FaceBook
  • Twitter
  • Pin It
  • Linkedin
  • Buffer
  • WhatsApp

Comments are closed.

Hey there.

So... you use an ad blocker. That's cool. Sometimes we do too.

But without ad revenue, we wouldn't even be here. And we might not be here much longer.

Please disable your ad blocker and click to continue.